Cetuximab in advanced non-small cell lung cancer

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Ramaswamy Govindan

Abstract

The epidermal growth factor receptor (EGFR) is frequently overexpressed in non-small cell lung cancer (NSCLC). EGFR activation results in phosphorylation of several downstream intracellular substrates involved in cell proliferation, angiogenesis, and inhibition of apoptosis. Cetuximab (C225, Erbitux), a monoclonal antibody directed against ligand binding in the extracellular domain of EGFR, inhibits tumor growth and is synergistic with chemotherapy and radiation. Cetuximab has been studied in combination with chemotherapy in previously untreated metastatic NSCLC. The response rates in preliminary reports range from 29% to 53%. In patients with refractory/recurrent NSCLC, the combination of docetaxel and cetuximab resulted in a promising response rate of 28%, higher than the typical response rates seen with docetaxel monotherapy in this setting. Addition of cetuximab to chemotherapy is generally well tolerated. Molecular mechanisms predicting response to cetuximab therapy are currently not well understood. Studies are ongoing to assess the single-agent activity of cetuximab in metastatic NSCLC.

References

Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F V FossellaB Glisson
Aug 24, 1999·Pharmacology & Therapeutics·J R Woodburn
Oct 6, 2000·Journal of the National Cancer Institute·T T ChenR Simon
May 4, 2001·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Y NakamuraT Nakashima
Jul 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F RobertH W Waksal
Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Apr 3, 2003·International Journal of Cancer. Journal International Du Cancer·Ahmedin JemalSusan S Devesa

❮ Previous
Next ❯

Citations

Jun 14, 2005·Trends in Molecular Medicine·Simone MocellinDonato Nitti
Aug 21, 2012·Biologics : Targets & Therapy·Nitin PatilHeike Allgayer
Mar 28, 2006·Future Oncology·Cheng-Long HuangMoritoshi Kinoshita
Oct 5, 2011·Journal of Medicinal Chemistry·Rania SoudyKamaljit Kaur
Feb 24, 2005·Current Opinion in Oncology·Fiona H BlackhallNicholas Thatcher
Jul 16, 2010·Expert Review of Molecular Diagnostics·Shaheenah Dawood
Apr 18, 2006·Seminars in Oncology Nursing·Polly Kay
Oct 29, 2005·Seminars in Thoracic and Cardiovascular Surgery·Eric M Toloza, Thomas A D'Amico
Sep 13, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hideharu KimuraKazuto Nishio
Nov 3, 2005·Expert Opinion on Emerging Drugs·Sofia Agelaki, Vassilis Georgoulias
Sep 1, 2007·Expert Opinion on Therapeutic Patents·Wenfang ShiQijun Qian
Dec 2, 2005·Expert Opinion on Pharmacotherapy·Giorgio Scagliotti
Oct 27, 2006·International Journal of Cancer. Journal International Du Cancer·Hila NovakYoram Reiter
Aug 18, 2005·Journal of the National Cancer Institute·John D MinnaAdi F Gazdar
Oct 20, 2007·Expert Review of Anticancer Therapy·Manrique AlvarezLuis E Raez
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William C Rose, Robert Wild
Apr 13, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James R TonraDaniel J Hicklin
Aug 20, 2014·Cancer Research·Toni M BrandDeric L Wheeler
Jan 21, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yelena Y JanjigianGregory J Riely
Apr 30, 2011·Archives of Pathology & Laboratory Medicine·Sanja Dacic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Masahiro FukuokaJose Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Leonard B SaltzRobert J Mayer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Román Pérez-SolerPhilip Bonomi
© 2022 Meta ULC. All rights reserved